Maintenance inhalers for COPD and asthma on every 2026 Guam Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in Guam cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$0.00/moS5820-035 |
|---|---|
| Trelegy Elliptafluticasone/umeclidinium/vilanterol | Tier 325%QL 60/30d |
| Breztri Aerospherebudesonide/glycopyrrolate/formoterol | Tier 325%QL 10.7/30d |
| Anoro Elliptaumeclidinium/vilanterol | Tier 325%QL 60/30d |
| Stiolto Respimattiotropium/olodaterol | Tier 325%QL 4/30d |
| Spirivatiotropium | Tier 325%QL 30/30d |
| Incruse Elliptaumeclidinium | Tier 325%QL 30/30d |
| Breo Elliptafluticasone/vilanterol | Tier 325%QL 60/30d |
| Symbicortbudesonide/formoterol | Tier 325%QL 10.2/30d |
| budesonide-formoterolgeneric Symbicort | Not covered |
| Advairfluticasone/salmeterol | Not covered |
| Wixela Inhubfluticasone/salmeterol, generic Advair | Tier 325%QL 60/30d |
| Duleramometasone/formoterol | Tier 425%QL 13/30d |
| Arnuity Elliptafluticasone furoate | Tier 325%QL 30/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.